0001842952-23-000026.txt : 20230214
0001842952-23-000026.hdr.sgml : 20230214
20230214170429
ACCESSION NUMBER: 0001842952-23-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230213
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Minai-Azary Jennifer Lynn
CENTRAL INDEX KEY: 0001844398
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40654
FILM NUMBER: 23631281
MAIL ADDRESS:
STREET 1: 110 MILLER AVENUE
STREET 2: SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Context Therapeutics Inc.
CENTRAL INDEX KEY: 0001842952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863738787
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 267-225-7416
MAIL ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: Context Therapeutics LLC
DATE OF NAME CHANGE: 20210128
4
1
wf-form4_167641222454214.xml
FORM 4
X0306
4
2023-02-13
0
0001842952
Context Therapeutics Inc.
CNTX
0001844398
Minai-Azary Jennifer Lynn
2001 MARKET STREET
SUITE 3915, UNIT #15
PHILADELPHIA
PA
19103
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
0.8407
2023-02-13
4
A
0
158001
0
A
2033-02-12
Common Stock
158001.0
158001
D
The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
/s/ Alex Levit, Attorney-in-Fact
2023-02-14